SK280597B6 - Cyklopeptidy, spôsob ich výroby, farmaceutický pro - Google Patents

Cyklopeptidy, spôsob ich výroby, farmaceutický pro Download PDF

Info

Publication number
SK280597B6
SK280597B6 SK1217-93A SK121793A SK280597B6 SK 280597 B6 SK280597 B6 SK 280597B6 SK 121793 A SK121793 A SK 121793A SK 280597 B6 SK280597 B6 SK 280597B6
Authority
SK
Slovakia
Prior art keywords
arg
asp
gly
phe
val
Prior art date
Application number
SK1217-93A
Other languages
English (en)
Slovak (sk)
Other versions
SK121793A3 (en
Inventor
Alfred Jonczyk
G�Nter H�Lzemann
Brunhilde Felding-Habermann
Friedrich Rippmann
Guido Melzer
Beate Diefenbach
Horst Kessler
Roland Haubner
Jochen Wermuth
Original Assignee
Merck Patent Gesellschaft Mit Beschr�Nkter Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gesellschaft Mit Beschr�Nkter Haftung filed Critical Merck Patent Gesellschaft Mit Beschr�Nkter Haftung
Publication of SK121793A3 publication Critical patent/SK121793A3/sk
Publication of SK280597B6 publication Critical patent/SK280597B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SK1217-93A 1992-11-06 1993-11-02 Cyklopeptidy, spôsob ich výroby, farmaceutický pro SK280597B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4237456A DE4237456A1 (de) 1992-11-06 1992-11-06 Cyclopeptide

Publications (2)

Publication Number Publication Date
SK121793A3 SK121793A3 (en) 1995-06-07
SK280597B6 true SK280597B6 (sk) 2000-04-10

Family

ID=6472232

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1217-93A SK280597B6 (sk) 1992-11-06 1993-11-02 Cyklopeptidy, spôsob ich výroby, farmaceutický pro

Country Status (21)

Country Link
EP (1) EP0596350B1 (xx)
JP (1) JP3681764B2 (xx)
KR (1) KR100238894B1 (xx)
CN (1) CN1038751C (xx)
AT (1) ATE154037T1 (xx)
AU (1) AU666586B2 (xx)
CA (1) CA2102447C (xx)
CZ (1) CZ286170B6 (xx)
DE (2) DE4237456A1 (xx)
DK (1) DK0596350T3 (xx)
ES (1) ES2105041T3 (xx)
GR (1) GR3024550T3 (xx)
HU (1) HU215600B (xx)
MX (1) MX9306885A (xx)
NO (1) NO309864B1 (xx)
PL (1) PL177772B1 (xx)
RU (1) RU2129563C1 (xx)
SK (1) SK280597B6 (xx)
TW (1) TW340849B (xx)
UA (1) UA43822C2 (xx)
ZA (1) ZA938281B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6944221B2 (ja) * 2017-11-20 2021-10-06 ノブメタファーマ カンパニー リミテッド Ｃｈｐ（シクロ−ヒスプロ）を含む骨損失疾患の予防、改善または治療用組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents

Also Published As

Publication number Publication date
MX9306885A (es) 1995-01-31
HU215600B (hu) 1999-01-28
TW340849B (en) 1998-09-21
CN1093090A (zh) 1994-10-05
DE59306654D1 (de) 1997-07-10
PL177772B1 (pl) 2000-01-31
KR940011479A (ko) 1994-06-21
KR100238894B1 (ko) 2000-01-15
CZ286170B6 (cs) 2000-02-16
EP0596350B1 (de) 1997-06-04
RU2129563C1 (ru) 1999-04-27
ES2105041T3 (es) 1997-10-16
NO309864B1 (no) 2001-04-09
DE4237456A1 (de) 1994-05-11
JPH0892282A (ja) 1996-04-09
NO934003D0 (no) 1993-11-05
PL300935A1 (en) 1994-05-16
ZA938281B (en) 1994-06-07
ATE154037T1 (de) 1997-06-15
AU666586B2 (en) 1996-02-15
UA43822C2 (uk) 2002-01-15
CZ235293A3 (en) 1994-07-13
EP0596350A1 (de) 1994-05-11
NO934003L (no) 1994-05-09
CA2102447C (en) 2007-04-10
JP3681764B2 (ja) 2005-08-10
GR3024550T3 (en) 1997-12-31
CN1038751C (zh) 1998-06-17
DK0596350T3 (da) 1997-12-29
HUT68321A (en) 1995-06-28
AU5039993A (en) 1994-05-19
CA2102447A1 (en) 1994-05-07
SK121793A3 (en) 1995-06-07

Similar Documents

Publication Publication Date Title
RU2157379C2 (ru) Циклопептиды, способ их получения, содержащая их фармацевтическая композиция, способ ее получения
CA2120303C (en) Cyclic adhesion inhibitors
AU697614B2 (en) Novel cyclopeptides for the preparation of medicaments
US5705481A (en) Cyclopeptides
CA2250861C (en) Cyclic adhesion inhibitors
IE913831A1 (en) Cyclopeptides
RU2174520C2 (ru) Циклопептидные производные
US6534478B1 (en) Cyclic azapeptides with angiogenic effect
SK280597B6 (sk) Cyklopeptidy, spôsob ich výroby, farmaceutický pro
JPH0665290A (ja) 線状ペプチド
CZ465899A3 (cs) Derivát cyklického azapeptidu s angiogenním působením

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20131102